Diabetes news and diabetes widget

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Nicholas A. Peppas has been elected to the Institute of medicine (IOM) of the National Academy of Sciences, becoming the first faculty member from The University of Texas at Austin to receive this honor -- the highest recognition a scientist or engineer in the medical sciences can receive in the United States.

A protein made by the liver in response to inflammation and used to treat patients suffering from a genetic form of emphysema has been shown to restore blood glucose levels in a mouse model of Type 1 diabetes mellitus, according to a new study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

New evidence discovered by researchers at The University of Texas School of Public health Brownsville Regional Campus shows that patients with Type 2 diabetes may be at increased risk of contracting tuberculosis because of a compromised immune system, resulting in life-threatening lung infections that are more difficult to treat. Blanca I. Restrepo, Ph.D., assistant professor of epidemiology; and Susan P. Fisher-Hoch, M.D., professor of epidemiology; and Joseph B. McCormick, M.D.

DiaKine Therapeutics, developers of drugs designed to cause diabetes to go into remission, announced today that a Phase 2 Clinical Trial with the Company's lead drug candidate, Lisofylline (LSF), is underway. Use of LSF may improve the long-term success of transplanting islets (the insulin-producing cells of the pancreas) into people with type 1 diabetes. The trial is part of the Clinical Islet Transplantation (CIT) Consortium created by National Institutes of health.

Title: Too Much Sun, Too Few Antioxidants Spell Eye TroubleCategory: health newscreated: 10/15/2008 2:00:00 amlast Editorial review: 10/15/2008